OQROGet OQRO Pro
Insider trade

Incyte (INCY)Officer sold ~$637K

Patrick A Mayes, Officer at Incyte, sold ~$637K of Incyte shares.

~$637K
Approx. value · 5,332 sh @ $119.42
83K
Holds after · shares reported
Traded
Jul 31, 2026
Filed
Aug 4, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jun 4, 2026InsiderOfficer sold ~$264K of INCY shares in the open market
  2. Jul 15, 2026Insider · 13 days before resultsOfficer sold ~$3.19M of INCY shares in the open market
  3. Jul 16, 2026Insider · 2 peopleInsiders: 2 sales (~$341K)
  4. Jul 28, 2026Company filing · Form 8-K · ResultsReported its results
  5. Jul 31, 2026 · this disclosureInsiderOfficer sold ~$637K of INCY shares in the open market

What came next

  1. Jul 31, 2026Insider · 2 peopleInsiders: 11 sales (~$6.3M)
  2. Aug 3, 2026InsiderOfficer sold ~$729K of INCY shares in the open market
  3. Aug 5, 2026Insider · 2 peopleInsiders: 2 sales (~$1.6M)
  4. Aug 12, 2026InsiderOfficer sold ~$1.3M of INCY shares in the open market
  5. Aug 19, 2026InsiderOfficer sold ~$1.36M of INCY shares in the open market
  6. Sep 15, 2026Insider · 1 personInsiders: 2 sales (~$2.8M)
  7. Sep 25, 2026FDAFDA drug approval: Atebrioz
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Incyte

For Incyte, OQRO holds 23 insider filings (SEC Form 4 or Form 144) and 14 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its INCY page.

Other recent filings by Patrick A Mayes, EVP & Chief Scientific Officer

The full history of Patrick A Mayes, EVP & Chief Scientific Officer is on the profile page.

How this filing works

Other disclosures at Incyte

Everything OQRO holds on this company is on its INCY page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data